GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
Novartis completes acquisition of majority stake in Zhejiang Tianyuan expanding vaccines presence in China
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
Sanofi-aventis Strengthens Commitment to Ophthalmology through Partnership with The Vision Institute
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](/images/stories/logo/sanofi-aventis.gif)
SPIRIVA HandiHaler Prolonged Time To First COPD Exacerbation
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Roche announces positive pivotal Phase II results for Hedgehog Pathway Inhibitor
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
Novartis receives European Commission approval for Gilenya®
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
More Pharma News ...
- GSK supports recovery efforts to help those affected by the Japan earthquake
- Novartis committed to provide equivalent of more than USD 3 million in relief aid to Japan earthquake victims
- MorphoSys Signs Manufacturing Agreement with Boehringer Ingelheim
- NAFE Names Lilly to Top 50 Companies for Executive Women
- GSK announces positive topline results of Phase lll study of IPX066 in advanced Parkinson's disease
- Amgen Donates $1 Million to Help Japanese Disaster Victims
- Abbott Supports Relief Efforts in Japan